» Authors » Soren L Kristensen

Soren L Kristensen

Explore the profile of Soren L Kristensen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 1664
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Butt J, Thune J, Nielsen J, Haarbo J, Videbaek L, Gustafsson F, et al.
Eur J Heart Fail . 2024 Aug; PMID: 39155576
Aims: Although body mass index (BMI) is the most commonly used anthropometric measure to assess adiposity, alternative indices such as the waist-to-height ratio may better reflect the location and amount...
2.
Glargaard S, Deis T, Abild-Nielsen A, Stark A, Thomsen J, Kristensen S, et al.
Circ Heart Fail . 2024 Aug; 17(9):e011253. PMID: 39105292
Background: Pleural effusion is present in 50% to 80% of patients with acute heart failure, depending on image modality. We aim to describe the association between the presence and size...
3.
Jacobsen J, Kristensen S, Fosbol E, Kober L, Westergaard L, Persson F, et al.
Diabetes Metab . 2024 Jun; 50(5):101551. PMID: 38914221
Aim: Diabetes mellitus (DM) and multiple sclerosis (MS) are two common diseases known to worsen the trajectory of each other, yet it is unknown whether MS is associated with incident...
4.
Schjodt I, Mols R, Bakos I, Horvath-Puho E, Gustafsson F, Kristensen S, et al.
ESC Heart Fail . 2024 Mar; 11(4):1919-1931. PMID: 38488159
Aims: Increasing numbers of patients with advanced heart failure and significant comorbidity and social barriers are considered for left ventricular assist devices (LVADs). We sought to examine health care utilization...
5.
Jacobsen J, Westergaard L, Fosbol E, Kristensen S, Kober L, Persson F, et al.
Diabetes Obes Metab . 2024 Feb; 26(5):1976-1979. PMID: 38355939
No abstract available.
6.
Yafasova A, Fosbol E, Gustafsson F, Krintel S, Kristensen S, Schou M, et al.
Chest . 2024 Jan; 166(1):136-145. PMID: 38295951
Background: Chronic inflammation is increasingly recognized as a risk factor for VTE, but unlike other inflammatory diseases including systemic lupus erythematosus and rheumatoid arthritis, data on the risk of VTE...
7.
Schjodt I, Mols R, Eiskjaer H, Bakos I, Horvath-Puho E, Gustafsson F, et al.
ASAIO J . 2023 Oct; 69(12):e482-e490. PMID: 37792681
The use of a left ventricular assist device (LVAD) in treating advanced heart failure has increased. However, data regarding medical treatment and adherence following LVAD implantation is sparse, particularly whether...
8.
Ettrup-Christensen A, Butt J, Andersen M, Sessa M, Polcwiartek C, Fosbol E, et al.
J Cardiovasc Dev Dis . 2023 Sep; 10(9). PMID: 37754791
Data on temporal trends in guideline-based medical and device therapies in real-world chronic heart failure (HF) patients are lacking. Register-based nationwide follow-ups of temporal trends in characteristics, guideline-recommended therapies, one-year...
9.
Larsson J, Denholt C, Thune J, Raja A, Fosbol E, Schou M, et al.
Eur Heart J Cardiovasc Pharmacother . 2023 Jun; 9(6):546-552. PMID: 37355774
Background: The mineralocorticoid receptor antagonists (MRAs) eplerenone and spironolactone are beneficial in heart failure with reduced ejection fraction (HFrEF), but have not been prospectively compared. We compared clinical outcomes, daily...
10.
Stahl A, Havers-Borgersen E, Ostergaard L, Petersen J, Bruun N, Weeke P, et al.
Am Heart J . 2023 Jun; 264:106-113. PMID: 37271357
Background: Patients with chronic renal failure on hemodialysis carry a significant risk of infective endocarditis (IE), but data on whether these patients differ from other patients with IE in terms...